Comparison between direct factor Xa inhibitors and low-molecular-weight heparin for efficacy and safety in the treatment of cancer-associated venous thromboembolism: A meta-analysis
Conclusions: Direct factor Xa inhibitors are superior to LMWH in efficacy in the treatment of VTE in cancer patients, and the safety between the two regimens is comparable except for a slightly higher rate of minor bleeding when the former is used.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Min Yang Jiang Li Rui Sun Yanfeng Wang Haiyan Xu Boyan Yang Xiaoming Wu Lei Yu Source Type: research
More News: Bleeding | Cancer | Cancer & Oncology | Clinical Trials | Databases & Libraries | Oral Cancer | Science | Study | Thrombosis